https://clinicaltrials.gov/ct2/show/study?term=Mente&rank=2
Study details updated on 15 December 2017, stating "Study Completion Date" was 13 December 2017, which the site defines as "The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "estimated" study completion date is the date that the researchers think will be the study completion date."
Re: NTI will soon double in shareprice!, page-16
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.55M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16000 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.9¢ | 189950 | 2 |
View Market Depth
| Last trade - 08.22am 25/11/2024 (20 minute delay) ? |
| NTI (ASX) Chart |
Day chart unavailable
